Catalog No.
YVV20401
Expression system
E. coli
Species
Human enterovirus 71 (EV71) (EV-71)
Protein length
Ser70-Gln323
Predicted molecular weight
54.54 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
W8YRS6
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Genome polyprotein, VP0, Capsid protein VP0
Development and characterization of an enterovirus 71 (EV71) virus-like particles (VLPs) vaccine produced in Pichia pastoris., PMID:31403352
Enterovirus type 71-immunized chicken egg yolk immunoglobulin has cross antiviral activity against coxsackievirus A16 in vitro., PMID:31258670
Determination of the cleavage site of enterovirus 71 VP0 and the effect of this cleavage on viral infectivity and assembly., PMID:31195113
Induction of immune responses by a novel recombinant fusion protein of enterovirus A71 in BALB/c mice., PMID:30465931
Artemisia capillaris inhibited enterovirus 71-induced cell injury by preventing viral internalization., PMID:29475462
A highly conserved amino acid in VP1 regulates maturation of enterovirus 71., PMID:28938017
Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challenges., PMID:27373596
Gan-Lu-Siao-Du-yin, a prescription of traditional Chinese medicine, inhibited enterovirus 71 replication, translation, and virus-induced cell apoptosis., PMID:26993050
Characterization of the antibody response against EV71 capsid proteins in Chinese individuals by NEIBM-ELISA., PMID:26023863
Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease., PMID:25855976
Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease., PMID:25833050
Structures of the procapsid and mature virion of enterovirus 71 strain 1095., PMID:23637404
Characterization of enterovirus 71 capsids using subunit protein-specific polyclonal antibodies., PMID:23046991
Development of murine monoclonal antibodies with potent neutralization effects on enterovirus 71., PMID:22771741
[The assemblage, purification and characterization of EV71 VLPs expressed in baculovirus]., PMID:22764520
Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system., PMID:21603631
[Expression of VP0 protein of enterovirus 71 in Escherichia coli and generation of the corresponding polyclonal antibodies in guinea pigs]., PMID:21557912
Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins., PMID:21295614
Expression, purification and characterization of enterovirus-71 virus-like particles., PMID:16521221
For research use only. Not for human or drug use.
